Loading insider details...
Beta
Latest Form 4 (Aug 11, 2026): Exercise/Conversion of 400 APVO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 11, 2026 | Aptevo Therapeutics Inc. (APVO) | Exercise/Conversion | 400 | n/a |
| Aug 8, 2025 | Aptevo Therapeutics Inc. (APVO) | Grant/Award | 7,200 | n/a |
| Jul 21, 2025 | Aptevo Therapeutics Inc. (APVO) | Exercise/Conversion | 1 | n/a |
| Jul 19, 2024 | Aptevo Therapeutics Inc. (APVO) | Grant/Award | 925 | n/a |
| Jun 3, 2024 | Aptevo Therapeutics Inc. (APVO) | Exercise/Conversion | 7 | n/a |
| Aug 10, 2023 | Aptevo Therapeutics Inc. (APVO) | Exercise/Conversion | 3,571 | n/a |
| Jun 2, 2023 | Aptevo Therapeutics Inc. (APVO) | Exercise/Conversion | 297 | n/a |
| Aug 10, 2022 | Aptevo Therapeutics Inc. (APVO) | Grant/Award | 3,571 | n/a |
| Jun 3, 2022 | Aptevo Therapeutics Inc. (APVO) | Exercise/Conversion | 298 | n/a |
| Jun 2, 2021 | Aptevo Therapeutics Inc. (APVO) | Grant/Award | 2,678 | n/a |